Wei Wei, Zhou Xiao-Mao, Wang Yu-Cheng, Lin Zhi-Cheng, Xue Ji-Hua
Affiliated Rehabilitation Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou 350003, China.
Institute of Fujian Rehabilitation Industry, Fuzhou 350003, China.
Zhongguo Zhong Yao Za Zhi. 2018 May;43(10):2147-2152. doi: 10.19540/j.cnki.cjcmm.20180104.025.
Alisol A 24-acetate, a triterpenoid extracted from Alisma orientale, has shown anti-atherosclerotic actions and many studies have proved that oxidized low density lipoprotein (Ox-LDL) could promote proliferation of aorta smooth muscle cells (VSMCs) which are closely related to atherosclerosis (AS). The purpose of this study was to evaluate the effect of alisol A 24-acetate on the proliferation of VSMCs isolated from the thoracic aorta of rats induced by ox-LDL. VSMCs were induced by ox-LDL(50 mg·L⁻¹) to establish the proliferation model and intervened by alisol A 24-acetate (5, 10, 20 mg·L⁻¹) for 12, 24 and 48 h. Then the proliferation of VSMCs was detected by MTT assay; protein expression levels of VSMCs PCNA, cyclinD1, cyclinE, p21, p27 and VSMCs PCNA, p21and p27 mRNA expression levels were detected by Western blot and Real-time polymerase chain reaction (RT-PCR) respectively. The results showed that ox-LDL could induce the proliferation of VSMCs (<0.05), increase the protein expression levels of PCNA, cyclinD1 and cyclinE in the VSMCs (<0.05) and inhibit the protein and mRNA expression levels of p21 and p27 (<0.05). As compared with the model group, alisol A 24-acetate inhibited the proliferation of VSMCs in rats induced by ox-LDL and inhibited the protein expression of VSMCs PCNA, cyclinD1, cyclinE and enhanced the protein and mRNA p21 and p27 expression levels (<0.05). The effect was more obvious with the increase of concentration of alisol A 24-acetate. These data indicate that alisol A 24-acetate can inhibit the proliferation of VSMCs induced by ox-LDL and the mechanism may be associated with inhibiting expression of cyclin protein, including cyclinD1, cyclinE, p21, p27 and so on.
泽泻醇A 24 - 乙酸酯是从东方泽泻中提取的一种三萜类化合物,已显示出抗动脉粥样硬化作用,许多研究证明氧化低密度脂蛋白(Ox-LDL)可促进与动脉粥样硬化(AS)密切相关的主动脉平滑肌细胞(VSMCs)增殖。本研究旨在评估泽泻醇A 24 - 乙酸酯对ox-LDL诱导的大鼠胸主动脉分离的VSMCs增殖的影响。用ox-LDL(50 mg·L⁻¹)诱导VSMCs建立增殖模型,并用泽泻醇A 24 - 乙酸酯(5、10、20 mg·L⁻¹)干预12、24和48小时。然后通过MTT法检测VSMCs的增殖;分别通过蛋白质印迹法和实时聚合酶链反应(RT-PCR)检测VSMCs增殖细胞核抗原(PCNA)、细胞周期蛋白D1、细胞周期蛋白E、p21、p27的蛋白表达水平以及VSMCs中PCNA、p21和p27的mRNA表达水平。结果表明,ox-LDL可诱导VSMCs增殖(<0.05),增加VSMCs中PCNA、细胞周期蛋白D1和细胞周期蛋白E的蛋白表达水平(<0.05),并抑制p21和p27的蛋白及mRNA表达水平(<0.05)。与模型组相比,泽泻醇A 24 - 乙酸酯抑制ox-LDL诱导的大鼠VSMCs增殖,抑制VSMCs中PCNA、细胞周期蛋白D1、细胞周期蛋白E的蛋白表达,并增强p21和p27的蛋白及mRNA表达水平(<0.05)。随着泽泻醇A 24 - 乙酸酯浓度的增加,作用更明显。这些数据表明,泽泻醇A 24 - 乙酸酯可抑制ox-LDL诱导的VSMCs增殖,其机制可能与抑制细胞周期蛋白包括细胞周期蛋白D1、细胞周期蛋白E、p21、p27等的表达有关。